DENTSPLY SIRONA (NASDAQ:XRAY) Stock Gets Price Target Reduction from JPMorgan Chase & Co.

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target decreased by research analysts at JPMorgan Chase & Co. from $12.00 to $10.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical instruments supplier’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 5.71% from the company’s current price.

Other equities analysts have also recently issued research reports about the company. Bank of America restated a “buy” rating on shares of DENTSPLY SIRONA in a report on Friday. Leerink Partners dropped their target price on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a report on Wednesday, October 14th. Barrington Research reduced their price target on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 26th. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Finally, Mizuho lowered their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Thursday, October 22nd. Three investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $12.42.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $9.46 on Friday. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -15.26, a PEG ratio of 1.27 and a beta of 0.87. DENTSPLY SIRONA has a 12 month low of $8.14 and a 12 month high of $14.76. The firm has a fifty day simple moving average of $9.60 and a 200 day simple moving average of $11.28. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The business had revenue of $836.00 million during the quarter, compared to analyst estimates of $861.68 million. During the same quarter in the previous year, the firm posted $0.37 earnings per share. The firm’s quarterly revenue was down 7.5% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Research analysts forecast that DENTSPLY SIRONA will post 1.33 EPS for the current fiscal year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently bought and sold shares of the business. Altar Rock LLC acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $131,000. AlphaCore Capital LLC increased its holdings in shares of DENTSPLY SIRONA by 9.9% during the 3rd quarter. AlphaCore Capital LLC now owns 14,386 shares of the medical instruments supplier’s stock worth $127,000 after acquiring an additional 1,298 shares during the last quarter. Private Management Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 18.9% during the 3rd quarter. Private Management Group Inc. now owns 2,936,998 shares of the medical instruments supplier’s stock worth $26,022,000 after acquiring an additional 466,272 shares during the last quarter. Fulcrum Asset Management LLP bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $249,000. Finally, Brighton Jones LLC raised its stake in DENTSPLY SIRONA by 7.6% in the 3rd quarter. Brighton Jones LLC now owns 37,673 shares of the medical instruments supplier’s stock valued at $334,000 after acquiring an additional 2,668 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.